Left ventricular assist device; Microaxial blood pump; High-risk percutaneous coronary intervention Abstract Percutaneous coronary intervention (PCI) has been increasingly performed in patients with severely depressed left ventricular function and complex coronary lesions, including multivessel disease.
In the setting of low coronary flow reserve, severely depressed left ventricular function and potential hemodynamic instability, the Impella CP ® device has made it possible to maintain hemodynamic stability during procedures, without being associated with vascular complications. © 2018 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights reserved. On admission, a transthoracic echocardiogram (TTE) showed severely depressed left ventricular ejection fraction (LVEF) (estimated 29%); akinesis of the apex, inferior wall, middle and distal segments of the anterior wall; and hypokinesis of the other walls. There was no evidence of intracavitary thrombi. Invasive coronary angiography revealed severe native coronary artery disease consisting of an occluded left anterior descending (LAD) artery at the origin and occluded left circumflex (LCX) and right coronary artery (RCA) in their middle segments. The SVG to LAD was occluded, the SVG to the OM1 had 90% stenosis proximally (pre-stent) and the SVG to the right posterior descending artery had 70% stenosis distally. The patient underwent cardiac magnetic resonance imaging (CMRI), which showed extensive myocardial scarring involving the apex, the inferior wall and the middle and distal segments of the anterior wall. Finally, an adenosine stress perfusion CMRI revealed ischemia of the basal segment of the inferolateral wall. Based on this evidence, and in an attempt to improve the patient's status, it was decided to perform a PCI of the SVG to the OM1. A 4-l/min Impella CP ® assist device was selected for support due to the low physiologic reserve of the patient and the relevance of the aforementioned graft in the perfusion of the remaining viable myocardium.t
PALAVRAS-CHAVE
Following local anesthesia, a 6-Fr sheath was inserted into the right femoral artery. After performing a contrast study of the aorta and both iliac arteries, the patient was considered a candidate for using the assist device. A 14-Fr sheath was then placed in the left femoral artery. After administration of 5000 units of unfractionated heparin (UFH), an angiographic pigtail diagnostic catheter (Cardinal Health) was used to deliver a specific 0.14-inch guidewire to the LV. The diagnostic catheter was then removed, and the Impella CP ® pump was advanced over the wire across the aortic valve under angiographic guidance ( Figure 1A) . The pump was started, with a maximum of 3.5 l per minute of circulatory support necessary to maintain the patient hemodynamically stable during the procedure.
The SVG to the OM1 was intubated with a 6-Fr Amplatz Left 1 catheter (Cardinal Health). A distal embolic protection device, the 6-Fr Emboshield NAV (Abbott Vascular), was gently passed into the SVG across the target lesion and was deployed at the distal portion of the graft ( Figure 1B) . After pre-dilation of the target lesion with a 3.5×20-mm TREK balloon (Abbott Vascular), a 4.0×28-mm Xience stent was successfully deployed in the SVG. Next, the stent was postdilated with a 4.5×15-mm Quantum TM Maverick TM balloon (Boston Scientific) at 18 atm. The Emboshield NAV basket was then carefully withdrawn. Aspiration was performed to clear the guide catheter of any debris and thrombi and ensure that none of the contents of the basket remained in the guiding catheter ( Figure 1C) .
The intervention was uneventful and the patient remained hemodynamically stable throughout the procedure. The Impella CP ® assist device was withdrawn at the end of the procedure and the left femoral artery access site was transcutaneously closed with two ProGlide (Abbott The role of Impella in high-risk percutaneous coronary intervention 623.e3 Vascular) devices, a suture-mediated closure system with threads made of non-resorbable 3-0 polypropylene. Vascular closure of the right femoral artery was achieved with Angio-Seal TM (St. Jude Medical), a device that employs a collagen plug that not only physically closes the arteriotomy site but also induces platelet activation and aggregation when deployed.
The patient was safely discharged from hospital two days later. After eight months, he reported class II angina according to Canadian Cardiovascular Society grading system and mild episodes of dyspnea on moderate effort.
Case 2
An 80-year-old male with type 2 diabetes, hypertension, dyslipidemia and a permanent pacemaker device implanted one year before due to complete heart block was transferred to our hospital with an acute myocardial infarction, Killip class III.
An electrocardiogram obtained immediately upon admission showed stable right ventricular pacing rhythm. TTE showed a severely depressed LVEF (34%) with global hypokinesis of the left ventricle. There was no evidence of intracavitary thrombi. Coronary angiogram revealed 70% stenosis of the distal left main coronary artery (LMCA) (Medina Classification 1,0,1) and chronic total occlusions of the proximal LCX and middle RCA, both partially perfused by collateral vessels (Figure 2A ). The patient was rejected for CABG because of high operative risk and poor distal grafting targets. After a Heart Team discussion, it was decided to proceed with a PCI of the distal LMCA to the LAD with the support of a 4-l/min Impella CP ® . The procedure started with the insertion of a 6-Fr sheath into the right radial artery. A contrast study of the aorta and both iliac arteries showed that the patient was a candidate for using the ventricular assist device. A 14-Fr sheath was then inserted into the right femoral artery and, after administration of 5000 units of UFH, the 4-l/min Impella CP ® assist device was placed into the left ventricle, as previously described. The device was started, with a maximum of 3.0 l/min of circulatory support necessary to maintain the patient hemodynamically stable during the procedure.
The ostium of the LMCA was catheterized using a 6-Fr Extra Back-Up 3.5 guiding catheter (Cardinal Health) via right radial artery. A Whisper (Abbott Vascular) guidewire was advanced into the LAD and multiple pre-dilation inflations were performed using a 2.5×8-mm Quantum TM Maverick TM balloon and a 3×8-mm TREK balloon. Then a 3.5×18-mm Onyx TM (Medtronic) stent was successfully deployed in the distal LMCA towards the proximal LAD. The stent was subsequently post-dilated with a 4.0×15mm Quantum TM Maverick TM balloon at 20 atm, with a good final angiographic result ( Figure 2B ). The patient remained hemodynamically stable throughout. The Impella CP ® assist device was withdrawn and the sheath was removed at the end of the procedure. The right femoral artery access site was closed using a ProGlide device.
The patient experienced a favorable clinical course and was discharged from hospital four days after the procedure. Five months later, he was free of chest pain and reported class II dyspnea according to the New York Heart Association Functional Classification.
Conclusion
In this manuscript, we presented two cases of high-risk PCI using the Impella CP ® device. In the setting of low coronary reserve, severely depressed LV function and potential hemodynamic instability, this device enabled hemodynamic stability to be maintained during the procedures without increasing vascular complications.
